Literature DB >> 16619035

Gene amplification and overexpression of protein phosphatase 1alpha in oral squamous cell carcinoma cell lines.

L-C Hsu1, X Huang, S Seasholtz, D M Potter, S M Gollin.   

Abstract

Gene amplification of chromosomal band 11q13 is observed frequently in oral squamous cell carcinomas (OSCC). Several genes have been identified in the 11q13 amplicon, including FGF3, FGF4, CCND1, EMS1 and TAOS1. Some of these genes show good correlation between gene copy number and gene expression, and are thought to play a role in driving 11q13 amplification. The PPP1CA gene, which encodes the catalytic subunit of serine/threonine protein phosphatase protein phosphatase 1alpha (PP1alpha), is also located in 11q13. Protein phosphatase 1alpha, one of the isoforms of PP1, regulates critical cellular events, such as cell cycle progression, and apoptosis. We sought to explore the possibility that PPP1CA was amplified and overexpressed in OSCC cells. Indeed, some OSCC cell lines had PPP1CA gene amplification, as analysed by fluorescence in situ hybridization. We have also demonstrated that PPP1CA gene copy number is increased in 21% of the OSCC cell lines determined by quantitative microsatellite analysis. PP1alpha RNA expression determined by quantitative reverse transcription-polymerase chain reaction was significantly higher in OSCC cell lines with 11q13 amplification compared to those without 11q13 amplification (P=0.011). The difference was even more significant between cell lines with at least three copies of the PPP1CA gene and those with less than three copies of the gene (P=0.00045). Relative PP1alpha protein levels were also significantly associated with PPP1CA gene copy number (P=0.014). Furthermore, knockdown of PP1alpha and/or cyclin D1 by small interfering RNA suppressed OSCC cell growth, at least in part by modulating pRB phosphorylation, resulting in G0 growth arrest. These data suggest that like the cyclin D1 gene, CCND1, amplification and overexpression of the PP1alpha gene, PPP1CA, may be involved in OSCC tumorigenesis and/or progression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16619035     DOI: 10.1038/sj.onc.1209563

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

1.  Identification and functional characterization of a PP1-binding site in BRCA1.

Authors:  Lih-Ching Hsu
Journal:  Biochem Biophys Res Commun       Date:  2007-06-26       Impact factor: 3.575

2.  A role for homologous recombination proteins in cell cycle regulation.

Authors:  Kaja Kostyrko; Sandra Bosshard; Zuzanna Urban; Nicolas Mermod
Journal:  Cell Cycle       Date:  2015-06-30       Impact factor: 4.534

3.  Phosphatases reverse p53-mediated cell cycle checkpoints.

Authors:  Lawrence A Donehower
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-07       Impact factor: 11.205

4.  Characterization of a fluorescent glucose derivative 1-NBDG and its application in the identification of natural SGLT1/2 inhibitors.

Authors:  Ting-Yu Kao; Hwa-Wei Wu; Shoei-Sheng Lee; Pi-Hui Liang; Jih-Hwa Guh; Lih-Ching Hsu
Journal:  J Food Drug Anal       Date:  2021-09-15       Impact factor: 6.157

5.  Nuclear Protein Phosphatase 1 α (PP1A) Expression is Associated with Poor Prognosis in p53 Expressing Glioblastomas.

Authors:  Arun H Shastry; Balaram Thota; Mallavarapu R Srividya; Arimappamagan Arivazhagan; Vani Santosh
Journal:  Pathol Oncol Res       Date:  2015-08-09       Impact factor: 3.201

6.  Multiple pathways in the FGF signaling network are frequently deregulated by gene amplification in oral dysplasias.

Authors:  Ivy F L Tsui; Catherine F Poh; Cathie Garnis; Miriam P Rosin; Lewei Zhang; Wan L Lam
Journal:  Int J Cancer       Date:  2009-11-01       Impact factor: 7.396

7.  Tumour suppressive microRNA-874 regulates novel cancer networks in maxillary sinus squamous cell carcinoma.

Authors:  N Nohata; T Hanazawa; N Kikkawa; D Sakurai; L Fujimura; T Chiyomaru; K Kawakami; H Yoshino; H Enokida; M Nakagawa; A Katayama; Y Harabuchi; Y Okamoto; N Seki
Journal:  Br J Cancer       Date:  2011-08-16       Impact factor: 7.640

8.  Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma.

Authors:  N Nohata; T Hanazawa; T Kinoshita; A Inamine; N Kikkawa; T Itesako; H Yoshino; H Enokida; M Nakagawa; Y Okamoto; N Seki
Journal:  Br J Cancer       Date:  2013-04-04       Impact factor: 7.640

9.  A PP1-binding motif present in BRCA1 plays a role in its DNA repair function.

Authors:  Young-Mi Yu; Serena M Pace; Susan R Allen; Chu-Xia Deng; Lih-Ching Hsu
Journal:  Int J Biol Sci       Date:  2008-10-04       Impact factor: 6.580

10.  An integrated analysis of genes and pathways exhibiting metabolic differences between estrogen receptor positive breast cancer cells.

Authors:  Soma Mandal; James R Davie
Journal:  BMC Cancer       Date:  2007-09-20       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.